AGP Limited

AGP

PK0113801010

Pharmaceuticals

End-of-day quote Pakistan S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
92.37 ^PKR	+3.21%		+2.33%	+31.38%

04-30	AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

AGP Limited Elects Zafar Iqbal Sobani as Director

June 06, 2018

AGP Limited announced that at the EGM held on June 7, 2018, the shareholders elected ZafarIqbal Sobani as director for a term of three years.

Latest news about AGP Limited

AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
AGP Limited Announces CEO Changes	12-14	CI
AGP Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/10/23	CI
AGP Limited Announces Board Changes	01/09/23	CI
AGP Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23	CI
AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
AGP Limited (KASE : AGP) completed the acquisition of Portfolio of Products of Viatris Inc.	07/04/23	CI
AGP Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23	CI
AGP Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/10/22	CI
AGP Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	31/08/22	CI
AGP Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	31/08/22	CI
AGP Limited (KASE : AGP) agreed to acquire Portfolio of Products of Viatris Inc.	14/06/22	CI
AGP Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Norway's Sikri to Buy Geographical Information Technology Consultancy Metria for $77 Million	01/04/22	MT
Flying Nickel Commissions Feasibility Study on Minago Nickel Project in Thompson Nickel Belt, Manitoba	16/03/22	MT
Japan's Osaka Gas enters India's urban gas distribution market	20/12/21	RE
AGP Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/10/21	CI
AGP Limited acquired Portfolio of 22 Pharmaceutical Products from Sandoz AG.	16/09/21	CI
AGP Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	26/08/21	CI
AGP Limited Reports Earnings Results for the First quarter Ended March 31, 2021	29/04/21	CI
Sikri : To Acquire Real Estate Technology Developer For $113.5 Million	19/04/21	MT
AGP Limited Approves Final Cash Dividend for the Year Ended December 31, 2020	26/02/21	CI
Agp Limited Reports Earnings Results for the Full Year Ended December 31, 2020	26/02/21	CI
Agp Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	29/10/20	CI

AGP Limited is a Pakistan-based pharmaceutical company. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of all kinds of pharmaceutical products. It owns a range of products catering to distinct therapeutic needs of the market. It offers a diverse portfolio of products in internal medicine, gynecology, pediatrics, nutraceutical, neuropsychiatry, cardiometabolic, hepatology, and orthopedic. Its products include Afdol, Nebcin, Exotan, Nergab, Febuxin, Zerifax, Protege, Maxna, Lucast, Urso, Kefzol, Algocin, Poze, Analar, Magnus MR, Novafol, Vita-NEM Plus, Colidrop, Daplazole, Lipomax, and Rigix, among others. Its subsidiary includes OBS AGP (Private) Limited (OBS AGP). OBS AGP is in the business of trading pharmaceutical products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AGP LIMITED	+31.38%	92.93M
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+43.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.21%	242B
ROCHE HOLDING AG	+2.17%	224B
NOVARTIS AG	+13.39%	218B
AMGEN INC.	+8.48%	168B

Other Pharmaceuticals

AGP Limited

Equities

AGP

PK0113801010

Pharmaceuticals

AGP Limited Elects Zafar Iqbal Sobani as Director

Latest news about AGP Limited

Chart AGP Limited

Company Profile

Income Statement Evolution

Chiffre d''affaires - Rate of surprise

Sector Other Pharmaceuticals